Page last updated: 2024-10-28

hypericin and Thyroid Carcinoma, Anaplastic

hypericin has been researched along with Thyroid Carcinoma, Anaplastic in 1 studies

Thyroid Carcinoma, Anaplastic: An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, H1
Kim, SW1
Seok, KH1
Hwang, CW1
Ahn, JC1
Jin, JO1
Kang, HW1

Other Studies

1 other study available for hypericin and Thyroid Carcinoma, Anaplastic

ArticleYear
Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
    Photodiagnosis and photodynamic therapy, 2018, Volume: 24

    Topics: Animals; Anthracenes; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Hum

2018